Table 2 |
||
|
Inhibitory effect of SB-203580 on hyperalgesia in the Hargraeves model |
||
|
COMPOUND |
PAW WITHDRAWAL TIME PRE-DRUG TREATMENT (Seconds) |
PAW WITHDRAWAL TIME POST-DRUG TREATMENT (Seconds) |
|
|
||
|
Vehicle |
10.7 ± 0.6 |
8.0 ± 0.8 |
|
|
||
|
Indomethacin (10 mg/kg) |
11.1 ± 0.6 |
14.5 ± 0.6* |
|
|
||
|
SB-203580 (30 mg/kg) |
10.8 ± 0.9 |
12.2 ± 1.2* |
|
|
||
|
SB-203580 (10 mg/kg) |
11.1 ± 0.6 |
11.8 ± 1.4* |
|
|
||
|
SB-203580 (3 mg/kg) |
12.0 ± 0.7 |
10.9 ± 1.2* |
|
|
||
|
The data are presented as the time for paw withdrawal from the heat source in seconds and are the mean ± S.E.M. from 10 rats per treatment group. The asterisk denotes a statistically significant difference (p < 0.05) between the vehicle and drug treatment groups. |
||
|
Brown et al. Journal of Inflammation 2008 5:22 doi:10.1186/1476-9255-5-22 |
||